Cardiovascular Institute

Dr. Murali and his staff have been involved in research for new PH treatments for the past 16 years. They have participated in many of the landmark clinical trials that have led to the development and FDA approval of currently available therapies. Clinical trials presently underway are exploring new treatment options such as an oral prostanoid, selective endothelin receptor blockers and combination strategies. In addition, epidemiologic and genetic studies are being pursued to explore the risk factors for PH and genetic modulation of treatment responses, which will further improve our ability to care for PH patients.

Researchers have been working to develop new and better treatments for PH. Some patients may be eligible to take part in one of these studies. Both the study team and the patient’s doctor follow the patient during the study. There is no fee to take part in these research studies. For more information, please call 412-359-6739.